Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
11.2 Capital

11.2 Capital

A venture capital and private equity firm focused on emerging technologies in artificial intelligence, cybersecurity, robotics, quantum, new space, computational therapeutics and synthetic biology.

11.2 Capital is a venture capital and private equity firm focused on emerging technologies in artificial intelligence, cybersecurity, robotics, quantum, new space, computational therapeutics and synthetic biology that is headquartered in San Francisco, California and was founded in 2014 by Shelley Zhuang. The firm specializes in offering its early stage companies several services such as technical recruiting, partnerships, customer introductions, and follow-on financing.

Notable investments made by 11.2 Capital include: TigerGraph, WhiteOps, Avaamo, Ginkgo Bioworks, Forter, Aunransa, Bay Labs, Cruise, Vertical, Notable Labs, Savioke, Molecular Assemblies, Kindred, Deep Genomics, and Lucira Health.

Timeline

2014
11.2 Capital was founded by Shelley Zhuang.

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.